These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia. Gunn IR; Wallace JR Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():52-8. PubMed ID: 1536526 [TBL] [Abstract][Full Text] [Related]
27. Filtering clinically significant hypercalcaemia from non-significant hypercalcaemia at the laboratory level. Frølich A; Friis Nielsen B; Conradsen K; McNair P Scand J Clin Lab Invest; 1993 May; 53(3):215-23. PubMed ID: 8316750 [TBL] [Abstract][Full Text] [Related]
29. Value of laboratory tests in the differential diagnosis of hypercalcemia. Boyd JC; Ladenson JH Am J Med; 1984 Nov; 77(5):863-72. PubMed ID: 6496541 [TBL] [Abstract][Full Text] [Related]
30. [Hypercalcemia due to parathyroid adenoma in a patient with earlier sarcoidosis]. Fäldt R Lakartidningen; 1971 Nov; 68(48):5523. PubMed ID: 5160282 [No Abstract] [Full Text] [Related]
31. Hyperparathyroidism: primary or secondary disease? Cordellat IM Reumatol Clin; 2012; 8(5):287-91. PubMed ID: 22089066 [TBL] [Abstract][Full Text] [Related]
32. The diagnosis and management of primary hyperparathyroidism. Dunne JV; Relihan M; Brady MP; O'Sullivan DJ J Ir Med Assoc; 1971 May; 64(411):251-5. PubMed ID: 5578249 [No Abstract] [Full Text] [Related]
33. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785 [TBL] [Abstract][Full Text] [Related]
34. [Primary hyperparathyroidism due to multiple eutopic and dystopic parathyroid adenomas]. Diethelm L; Gerok W; Kümmerle F; Pabst K; Hennekeuser HH Dtsch Med Wochenschr; 1969 Dec; 94(50):2593-7. PubMed ID: 5357429 [No Abstract] [Full Text] [Related]
35. Laboratory differentiation of hypercalcemic patients. Johnson KR; Howarth AT; Hamilton M; Mascall GC Clin Chem; 1982 Feb; 28(2):333-8. PubMed ID: 7055954 [TBL] [Abstract][Full Text] [Related]
36. Hypocalciuric hyperparathyroidism with chronic renal failure. Kirschbaum BB; Sica DA; Hom BM; Newsome HH South Med J; 1983 Aug; 76(8):1075-6. PubMed ID: 6879285 [TBL] [Abstract][Full Text] [Related]
37. Vitamin D-resistant rickets and parathyroid adenomas: renal transport of phosphate. Talwalkar YB; Musgrave JE; Buist NR; Campbell RA; Campbell JR Am J Dis Child; 1974 Nov; 128(5):704-8. PubMed ID: 4371252 [No Abstract] [Full Text] [Related]
39. Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions. Brossard JH; Whittom S; Lepage R; D'Amour P J Clin Endocrinol Metab; 1993 Aug; 77(2):413-9. PubMed ID: 8345045 [TBL] [Abstract][Full Text] [Related]